CIK 0000715446 · Non-accelerated filer<br>Smaller reporting company
Anixa Biosciences Inc
Sign in to watch- Ticker
- ANIX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Oct 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 112622630
- Phone
- 408-708-9808
- Business address
- 3150 ALMADEN EXPRESSWAY, SUITE 250, SAN JOSE, CA, 95118
- Former names
- ITUS Corp, COPYTELE INC
- DEF 14A Proxy Proxy Statement
- 10-Q Report Quarterly Report
- 10-Q/A Report 10-Q/A
- 3 Insider Initial Statement of Ownership
- 8-K Event Executive or director change
- UPLOAD Other SEC-generated Letter
- CT ORDER Other Confidential Order
- SC 13D/A Stake Beneficial Ownership Report
- S-8 Other Securities Offered to Employees in Benefit Plans
- 8-K Event Executive or director change
- CORRESP Other Correspondence Between Filers and SEC Staff
- 10-K/A Report 10-K/A
- 10-Q Report Quarterly Report
- UPLOAD Other SEC-generated Letter
- DFAN14A Other Proxy Soliciting Materials
- SC 13D Stake Beneficial Ownership Report
- PREC14A Other PREC14A
- SC 13G/A Stake Amended Statement of Ownership
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
Page 39 of 50 · 983 filings